Authors:
Tang, CY
Shou, MG
Rushmore, TH
Mei, Q
Sandhu, P
Woolf, EJ
Rose, MJ
Gelmann, A
Greenberg, HE
De Lepeleire, I
Van Hecken, A
De Schepper, PJ
Ebel, DL
Schwartz, JI
Rodrigues, AD
Citation: Cy. Tang et al., In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelicvariant forms of human liver microsomal cytochrome P4502C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics, PHARMACOGEN, 11(3), 2001, pp. 223-235
Authors:
Sarau, HM
Griswold, DE
Bush, B
Potts, W
Sandhu, P
Lundberg, D
Foley, JJ
Schmidt, DB
Webb, EF
Martin, LD
Legos, JJ
Whitmore, RG
Barone, FC
Medhurst, AD
Luttmann, MA
Giardina, GAM
Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
Citation: De. Lynch et al., 1 : 1 molecular complexes of 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (sulfamethazine) with indole-2-carboxylic acid and 2,4-dinitrobenzoic acid, AUST J CHEM, 53(5), 2000, pp. 383-387
Authors:
Puddephat, IJ
Thompson, N
Robinson, HT
Sandhu, P
Henderson, J
Citation: Ij. Puddephat et al., Biolistic transformation of broccoli (Brassica oleracea var. italica) for transient expression of the beta-glucuronidase gene, J HORT SCI, 74(6), 1999, pp. 714-720